Our observations are consistent with the notion that, while in neuroendocrine tumors p16Ink4A status mirrors the biologic features of higher-grade neoplasms, the expression of this protein in lung non-neuroendocrine malignancies is related to earlier step of tumorigenesis. This evidence concerns the gene CDKN2A and neuroendocrine neoplasm.